Manufacturer
ELI LILLY AND COMPANY
Contents
Ramucirumab
Indication
Metastatic colorectal cancer, Advanced gastric carcinoma, Gastro-oesophageal junction adenocarcinoma, Locally advanced non-small cell lung carcinoma, Metastatic non-small cell lung carcinoma.
Instruction
Withdraw appropriate volume and dilute with NaCl 0.9% to a final volume of 250 mL. Mix by gentle inversion. Do not shake.Administered via infusion over 1 hour.
Drug interaction
Not known.
Malaysia
